Arent Fox attorneys D. Jacques Smith, Randall Brater, and Michael Dearington spoke with Bloomberg Law about an upcoming US Supreme Court case and its potential ramifications for False Claims Act cases.
Joel Wallace was quoted on a recent ruling from Federal Judge Reed O’Connor in the Federal District Court in Fort Worth, Texas, that the Affordable Care Act’s (ACA) individual coverage mandate is unconstitutional and, in the absence of the individual mandate, the rest of the ACA cannot stand.
Managing Partner Marci Eisenstein was quoted on the importance of diversity in law firm leadership.
Earlier this month, Arent Fox LLP received the “Best Deal of the Year” award from the Washington DC Economic Partnership for a deal financing the acquisition of a new training center for the Spanish Education and Development Center.
Intellectual Property Practice Group Co-Leader Imron Aly was quoted on how including patents in the U.S. Food and Drug Administration’s “Purple Book” — which lists biological products, including any biosimilar and interchangeable biological products — might affect developers.
On December 5, New York partner Hunter Carter spoke before the Inter-American Commission on Human Rights.
On December 4, Complex Litigation Partner James H. Hulme was elected Vice President of the Council for Court Excellence at the nonprofit’s semi-annual board meeting held in the US District Court for the District of Columbia.
Intellectual Property Practice Group Co-Leader Imron Aly described the three key features of the U.S. Food and Drug Administration’s Biosimilar Action Plan: education, interchangeability, and international data sharing.
White Collar Defense and Government Investigations Practice Group Leader Maggie Hickey was quoted on the business leadership strategy behind a company choosing not to send their Chief Executive Officer (CEO) to a trial or congressional hearing.
Managing Partner Marci Eisenstein was quoted on putting clients’ needs and preferences first in offering a range of pricing options, with a majority of clients still expecting an hourly billing approach.
Hatch-Waxman and Biosimilars Practice Group Leader Imron Aly was quoted on why patients in the United States may have to wait longer than those in the European Union for the biosimilar adalimumab, referencing the brand name drug, Humira.
Schiff Hardin was featured on the steps the firm is taking to promote mental health and wellness among attorneys and staff.
Partner David Loring was quoted on the U.S. Environmental Protection Agency’s (EPA) recent reconsideration and approval of an EPA 2009 final action.
The Recorder has selected Eva Pulliam, a Senior Associate in Arent Fox’s Privacy, Cybersecurity & Data Protection group, as a “Next Generation Leader” in their 2018 list of Women Leaders in Tech Law.
AF Senior Government Relations Advisor Phil English spoke with the Philadelphia Enquirer following the 2018 midterm elections:
Intellectual Property Practice Group Co-Leader Imron Aly spoke with The Center for Biosimilars on key takeaways from the long-running case Saint Regis Mohawk Tribe, Allergan v. Mylan
Automotive leader Aaron Jacoby spoke with Law360 about how the construction industry is already considering how automated vehicles could be used on job sites and change infrastructure and development projects.
Partner Andrew Sawula, co-founder and leader of the firm’s Disability Inclusion Group, explained how making disability accommodations available to all attorneys helps combat the stigma associated with having a physical or mental health disability.
Much has been written about the problem of the stagnating electricity market due to a combination of falling demand, widespread energy efficiency initiatives, lower electricity costs, and aging infrastructure.